To determine whether C3-liposome delivery of MUC1 peptide with TLR agonists slows tumor growth, mice were challenged with MUC1-transfected Lewis lung carcinoma (LLC) tumor cells fourteen days following vaccination, and the mice were monitored for tumor growth. Here, MUC1 is linked to neoplasm.